New Deal
Hal Barron
Chief Scientific Officer & President at GLAXOSMITHKLINE PLC
Manager
Deal Bio
Expertise (3)
Key Relationships
Announcement Date
Deal Value
Tesaro
Glaxosmithkline
£3,371m
40 dealmakers
Vir Biotechnology
£203m
2 dealmakers
Affinivax
£2,610m
27 dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.